Drreddys Laboratories | RDY - Pre Utilidad Fiscal





Pre Utilidad Fiscal Cambio Fecha
ANI Pharmaceuticals USD 31.48M 18.04M 2025-12
Aurora Cannabis CAD -1.58M 48.55M 2025-12
Bayer EUR -3.37B 2.21B 2025-12
Canopy Growth CAD -62.26M 60.84M 2025-12
Cipla INR 7.49B 4.2B 2026-03
Corcept Therapeutics USD 9.91M 5.33M 2025-12
Drreddys Laboratories INR 15.43B 1.96B 2025-12
GlaxoSmithKline GBP 2.14B 919M 2026-03
Hikma Pharmaceutical USD 147.5M 3.5M 2025-06
Lonza CHF 624M 197M 2024-12
Novartis USD 3.84B 802M 2026-03
Pacira USD 571K 8.95M 2025-12
Phibro Animal Health USD 38.62M 1.26M 2025-12
Prestige Brands USD 61.81M 7.32M 2025-12
Richter Gedeon HUF 78.56B 32.66B 2024-12
Sun Pharmaceuticals INR 42.27B 595.5M 2025-12
Supernus Pharmaceuticals USD -5.95M 4.04M 2026-03
Teva Pharmaceutical Industries USD 753M 662M 2026-03